Trial intelligence / Profile preview

Learn to Quit-HIV vs QuitGuide for Smoking Cessation in HIV

NCT04609514Completed

Sponsor
Duke University
Start
Jan 2021
Primary completion
Jun 2022
Countries
1
01

Overview

Randomised, open-label trial (2 arms), sponsored by Duke University. Primary endpoints: Duration of Daily App Use at 3 months, Frequency of App Use as Measured by Interactions Per Day at 3 months and 3 more. Started Jan 2021; status: completed.

Beyond the preview

Go deeper on NCT04609514.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04609514.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call